Hundreds of thousands of patients with advanced head and neck cancer could live years longer without the disease, thanks to a breakthrough immunotherapy drug,...
Pfizer Inc. has said it will discontinue development of its closely watched obesity pill, danuglipron, dealing a severe blow to the company’s ambitions to...
A ground-breaking cancer therapy being tested in China is offering new hope for patients with advanced malignancies, particularly those who have exhausted conventional treatment...